Telephone
61.3.9550.8100
Address
30-32 Compark Circuit Mulgrave, Victoria (VIC) 3170
Description
Hydrix Ltd. engages in the development, design, and commercialization of technologies in the micro-electronic-mechanical systems (MEMS) sensor industry. It operates through the following segments: Hydrix Services, Hydrix Medical, Hydrix Digital, and Hydrix Ventures. The company was founded in May 2001 and is headquartered in Mulgrave, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.06
Trade Value (12mth)
AU$1,165.00
1 week
11.11%
1 month
0%
YTD
-60%
1 year
-67.21%
All time high
20.637
EPS 3 yr Growth
-95.300%
EBITDA Margin
-20.40%
Operating Cashflow
-$3m
Free Cash Flow Return
-39.60%
ROIC
-5.00%
Interest Coverage
-6.00
Quick Ratio
0.80
Shares on Issue (Fully Dilluted)
254m
HALO Sector
Technology
Next Company Report Date
27-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 October 22 |
Change of Registry Address
×
Change of Registry Address |
31 October 19 |
2019 Annual General Meeting Date
×
2019 Annual General Meeting Date |
31 October 19 |
2019 Annual Report to shareholders
×
2019 Annual Report to shareholders |
31 March 22 |
Becoming a substantial holder
×
Becoming a substantial holder |
31 July 23 |
Proposed issue of securities - HYD
×
Proposed issue of securities - HYD |
31 July 23 |
Quarterly Activities/App 4C & Convertible Note Capital Raise
×
Quarterly Activities/App 4C & Convertible Note Capital Raise |
31 July 23 |
Investor Presentation
×
Investor Presentation |
31 January 22 |
Quarterly Activities Report
×
Quarterly Activities Report |
31 January 22 |
Appendix 4C
×
Appendix 4C |
31 January 22 |
Application for quotation of securities - HYD
×
Application for quotation of securities - HYD |
30 September 22 |
Application for quotation of securities - HYD
×
Application for quotation of securities - HYD |
30 September 22 |
Application for quotation of securities - HYD
×
Application for quotation of securities - HYD |
30 September 22 |
Cleansing Notice
×
Cleansing Notice |
30 September 22 |
Appendix 3Y x 5
×
Appendix 3Y x 5 |
30 October 20 |
Investor Presentation
×
Investor Presentation |
30 November 22 |
2022 AGM - Executive Chairman's Presentation
×
2022 AGM - Executive Chairman's Presentation |
30 November 22 |
2022 AGM - Results of Meeting
×
2022 AGM - Results of Meeting |
30 June 21 |
Investor Presentation - AngelMed Guardian FDA Approval
×
Investor Presentation - AngelMed Guardian FDA Approval |
30 August 22 |
FY2022 Appendix 4E and Financial Report
×
FY2022 Appendix 4E and Financial Report |
29 September 22 |
Contract with Cyban Pty Ltd and Further Cleansing Notice
×
Contract with Cyban Pty Ltd and Further Cleansing Notice |
29 September 21 |
Annual General Meeting and Director Nomination Closing Date
×
Annual General Meeting and Director Nomination Closing Date |
29 October 21 |
Investor Presentation
×
Investor Presentation |
29 June 22 |
Option Expiry Notice
×
Option Expiry Notice |
29 July 22 |
Appendix 2A
×
Appendix 2A |
29 August 23 |
FY2023 Appendix 4E and Financial Report
×
FY2023 Appendix 4E and Financial Report |
29 August 23 |
FY2023 Results Announcement
×
FY2023 Results Announcement |
29 August 23 |
FY2023 Letter from Executive Chairman
×
FY2023 Letter from Executive Chairman |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.